CAR-T cell therapy for multiple myeloma involves several steps and can lead to various side effects. Here’s what you can generally expect:

1. Preparation: Before receiving CAR-T cells, patients often undergo a process called lymphodepletion, which involves chemotherapy to prepare the body.

2. Infusion: The genetically Show Full Answer

CAR-T cell therapy for multiple myeloma involves several steps and can lead to various side effects. Here’s what you can generally expect:

1. Preparation: Before receiving CAR-T cells, patients often undergo a process called lymphodepletion, which involves chemotherapy to prepare the body.

2. Infusion: The genetically modified CAR-T cells are then infused into the patient’s body through an IV.

3. Monitoring: Post-infusion, patients typically stay in the hospital for a few weeks to monitor the effectiveness and manage any side effects.

4. Side Effects: Common side effects include fever, fatigue, cytokine release syndrome (CRS), and neurological effects. Most side effects are manageable with medical care.

5. Post-Treatment Care: After discharge, patients might need to stay near the treatment center for additional weeks for further monitoring.

It's important to discuss all potential risks and benefits with your healthcare provider to understand what to expect based on your specific health situation.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Gene-Based Therapy May Thwart a Tough Blood Cancer | MyMyelomaTeam